Current NDC auxiliary source row compounder:451

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 73177-120
Product Ndc: 73177-120
Product Ndc Digits: 73177120
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Lidocaine Hydrochloride
Proprietary Name Suffix: [empty]
Nonproprietary Name: Lidocaine Hydrochloride
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: STAQ Pharma Inc
Establishment Name: STAQ Pharma Inc
Establishment Fei: [empty]
Substance Name: LIDOCAINE HYDROCHLORIDE
Active Ingredients Info: 20 mg/1 mL
History Active Ingredients Raw: LIDOCAINE HYDROCHLORIDE
History Active Ingredients Info Raw: 20 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 73177-120-02
Package Ndc: 73177-120-02
Package Ndc Digits: 7317712002
Package Ndc11: 73177012002
Package Description: 5 mL in 1 SYRINGE, PLASTIC (73177-120-02)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:451
Source Row Number: 451
Source Row Hash: 3f13a9279de5da2b84a0fec96f7f92e27a058c848a80c4eee00e6be104f47680
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "73177-120",
    "DEASCHEDULE": "",
    "LABELERNAME": "STAQ Pharma Inc",
    "SUBSTANCENAME": "LIDOCAINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "73177-120-02",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Lidocaine Hydrochloride",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Lidocaine Hydrochloride",
    "PACKAGEDESCRIPTION": "5 mL in 1 SYRINGE, PLASTIC (73177-120-02) ",
    "ACTIVEINGREDIENTSINFO": "20 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:451
Source Row Number: 451
Status Scope: package
Lookup Ndc: 73177-120-02
Lookup Ndc Digits: 7317712002
Product Ndc: 73177-120
Product Ndc Digits: 73177120
Package Ndc: 73177-120-02
Package Ndc Digits: 7317712002
Package Ndc11: 73177012002
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 3f13a9279de5da2b84a0fec96f7f92e27a058c848a80c4eee00e6be104f47680
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20